FDA Inspection
Xttrium Laboratories, Inc.Xttrium Laboratories, Inc. – FDA Inspection, May 25, 2016
Record Details
This FDA Inspection record concerns Xttrium Laboratories, Inc., with an inspection on May 25, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Xttrium Laboratories, Inc.
- Inspection Date
- May 25, 2016
- Product Type
- Drugs
View Company Profile
ID · 5efb9150-ee25-4e3c-a224-e8f64be350ec
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 985062
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Xttrium Laboratories, Inc.
15| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2026 | Not classified | Chicago District Office | |
| June 18, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 15, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Xttrium Laboratories, Inc.
- FDA Inspection 1324176 - 2026-06-16
- FDA Inspection 1273417 - 2025-06-18
- FDA Inspection 1234354 - 2024-03-08
- FDA Inspection 1230448 - 2024-02-06
- FDA Inspection 1046665 - 2018-03-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.